赛诺菲
SNY49.660USD
+0.170+0.34%
收盘 11/07, 16:00（美东）报价延迟15分钟
120.88B总市值
11.81市盈率 TTM
关于 赛诺菲 公司
赛诺菲 SA 是一家总部位于法国的医疗保健公司。该公司专注于患者需求，从事治疗解决方案的研究、开发、制造和营销。其三个运营部门为：制药、消费者保健 (CHC) 和疫苗。制药包括：免疫学、多发性硬化症/神经病学、肿瘤学、罕见疾病、罕见血液病、心血管、糖尿病、成熟处方产品。疫苗部门包括所有地理区域的赛诺菲巴斯德商业运营以及专门针对疫苗的研究、开发和生产活动。CHC 部门包括赛诺菲消费者保健产品的商业运营以及专门针对这些产品的研究、开发和生产活动。该公司合作或特许经营开发的产品包括 Dupixent、Aubagio、Lemtrada、Cerezyme、Lumizyme、Jevtana 和 Fabrazyme。
赛诺菲简介
公司代码SNY
公司名称Sanofi SA
上市日期Jul 01, 2002
CEOMr. Paul Hudson, Ph.D.
员工数量84587
证券类型Depository Receipt
年结日Jul 01
公司地址46 Avenue de la Grande Armee
城市PARIS
上市交易所NASDAQ Global Select Consolidated
国家France
邮编75017
电话33153774000
网址https://www.sanofi.com/
公司代码SNY
上市日期Jul 01, 2002
CEOMr. Paul Hudson, Ph.D.
赛诺菲公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Dr. Jean-Paul Kress, M.D.
Dr. Jean-Paul Kress, M.D.
Independent Director
Independent Director
--
--
Mr. Emile Voest, M.D., Ph.D.
Mr. Emile Voest, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Antoine Yver, M.D.
Dr. Antoine Yver, M.D.
Independent Director
Independent Director
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Ms. Fabienne Lecorvaisier
Ms. Fabienne Lecorvaisier
Independent Director
Independent Director
--
--
Ms. Audrey Duval Derveloy
Ms. Audrey Duval Derveloy
Executive Vice President - Corporate Affairs, Member of the Executive Committee
Executive Vice President - Corporate Affairs, Member of the Executive Committee
--
--
Ms. Clotilde Delbos
Ms. Clotilde Delbos
Independent Director
Independent Director
--
--
Mr. Frederic Oudea
Mr. Frederic Oudea
Independent Chairman of the Board
Independent Chairman of the Board
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Dr. Jean-Paul Kress, M.D.
Dr. Jean-Paul Kress, M.D.
Independent Director
Independent Director
--
--
Mr. Emile Voest, M.D., Ph.D.
Mr. Emile Voest, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Olivier Charmeil
Mr. Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Executive Vice President - General Medicines, Member of the Executive Committee
--
--
Dr. Antoine Yver, M.D.
Dr. Antoine Yver, M.D.
Independent Director
Independent Director
--
--
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暂无数据
地区USD
名称
营收
占比
United States
5.53B
48.81%
Rest of the World (Japan, South Korea, Canada, Australia, New Zealand)
4.21B
37.18%
Europe
2.38B
21.02%
业务
地区
暂无数据
股东统计
更新时间: 11月6日 周四
更新时间: 11月6日 周四
持股股东
股东类型
持股股东
持股股东
占比
Dodge & Cox
2.95%
Fisher Investments
0.54%
Invesco Advisers, Inc.
0.35%
Capital World Investors
0.34%
Managed Account Advisors LLC
0.31%
其他
95.51%
持股股东
持股股东
占比
Dodge & Cox
2.95%
Fisher Investments
0.54%
Invesco Advisers, Inc.
0.35%
Capital World Investors
0.34%
Managed Account Advisors LLC
0.31%
其他
95.51%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
5.25%
Investment Advisor
4.05%
Research Firm
0.77%
Hedge Fund
0.13%
Bank and Trust
0.07%
Family Office
0.02%
Pension Fund
0.02%
其他
89.69%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1265
250.84M
10.30%
-26.91M
2025Q2
1261
264.33M
10.86%
-14.23M
2025Q1
1286
268.29M
10.62%
-13.21M
2024Q4
1263
270.44M
10.70%
-30.67M
2024Q3
1239
286.03M
11.43%
-5.72M
2024Q2
1248
275.46M
11.01%
-5.50M
2024Q1
1232
261.25M
10.33%
-7.62M
2023Q4
1213
251.25M
9.93%
-18.33M
2023Q3
1178
256.18M
10.15%
-15.97M
2023Q2
1173
257.65M
10.20%
-26.92M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Dodge & Cox
71.72M
2.95%
-1.47M
-2.01%
Jun 30, 2025
Fisher Investments
13.14M
0.54%
-430.96K
-3.18%
Jun 30, 2025
Invesco Advisers, Inc.
8.56M
0.35%
-2.81M
-24.69%
Jun 30, 2025
Capital World Investors
8.35M
0.34%
+30.14K
+0.36%
Jun 30, 2025
Managed Account Advisors LLC
7.48M
0.31%
-87.85K
-1.16%
Jun 30, 2025
Barrow Hanley Global Investors
7.28M
0.3%
-68.91K
-0.94%
Jun 30, 2025
T. Rowe Price Associates, Inc.
5.52M
0.23%
-5.51M
-49.93%
Jun 30, 2025
Wellington Management Company, LLP
4.33M
0.18%
-96.41K
-2.18%
Jun 30, 2025
Putnam Investment Management, L.L.C.
4.13M
0.17%
+408.18K
+10.97%
Jun 30, 2025
Boston Partners
3.99M
0.16%
-100.31K
-2.45%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月5日 周三
更新时间: 11月5日 周三
机构名称
占比
VanEck Pharmaceutical ETF
4.44%
Invesco International Dividend Achievers ETF
2.84%
Altrius Global Dividend ETF
2.16%
Brandes US Value ETF
1.97%
Putnam Focused Large Cap Value ETF
1.82%
American Century Focused Large Cap Value ETF
1.48%
ProShares Ultra Nasdaq Biotechnology
1.31%
Invesco Nasdaq Biotechnology ETF
1.28%
Invesco ESG NASDAQ Next Gen 100 ETF
0.82%
Invesco NASDAQ Next Gen 100 ETF
0.73%
查看更多
VanEck Pharmaceutical ETF
占比4.44%
Invesco International Dividend Achievers ETF
占比2.84%
Altrius Global Dividend ETF
占比2.16%
Brandes US Value ETF
占比1.97%
Putnam Focused Large Cap Value ETF
占比1.82%
American Century Focused Large Cap Value ETF
占比1.48%
ProShares Ultra Nasdaq Biotechnology
占比1.31%
Invesco Nasdaq Biotechnology ETF
占比1.28%
Invesco ESG NASDAQ Next Gen 100 ETF
占比0.82%
Invesco NASDAQ Next Gen 100 ETF
占比0.73%
分红派息
近5年累计派现
23.51B
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Mar 26, 2024
SNY.NB Final Cash Dividend of gross USD 2.036908 paid on Jun 06, 2024 going ex on May 09, 2024
May 10, 2024
Jun 06, 2024
May 09, 2024
Feb 15, 2023
SNY.NB Final Cash Dividend of gross USD 1.900085 paid on Jun 23, 2023 going ex on May 30, 2023
May 31, 2023
Jun 23, 2023
May 30, 2023
Apr 20, 2022
SNY.NB Final Cash Dividend of gross USD 1.74684 paid on May 31, 2022 going ex on May 04, 2022
May 05, 2022
May 31, 2022
May 04, 2022
Mar 24, 2021
SNY.NB Final Cash Dividend of gross USD 1.928784 paid on May 26, 2021 going ex on May 03, 2021
May 04, 2021
May 26, 2021
May 03, 2021
Mar 05, 2020
SNY.NB Final Cash Dividend of gross USD 1.699399 paid on May 26, 2020 going ex on Apr 30, 2020
May 01, 2020
May 26, 2020
Apr 30, 2020
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
